Biotech
Better Care Acquires Digital Health Company DigitoMedica
BC Link from Better Care, a data integration platform compatible with all complex monitoring devices connected to a patient that allows them to be processed, interpreted, and stored in real-time to track your status. These data can be used in the decision-making of the health team, the optimization of health resources, the formulation of medical hypotheses, and even the prediction of possible critical events.
The Spanish biotechnology company Better Care, which develops software solutions based on artificial intelligence (AI) for continuous patient monitoring, has announced today the integration of DigitoMedica, a company specialized in the implementation of technology platforms for the health sector for patient management monitored in primary and specialized care, as well as in-home hospitalization. This operation means that Better Care increases the workforce to twenty people and that, in addition to its headquarters in Sabadell (Barcelona), it adds an office in Valencia.
With this integration, Better Care takes another step in its growth strategy and enhances its value proposition for the digital transformation of hospital management, offering a personalized service that allows monitoring of all clinical data generated by medical devices connected to the patient, as well as such as analytical and pharmacological information, at any point of the care route, inside and outside the hospital, thus guaranteeing continuity of care.
Starting from its origins as a spin-off of the Research and Innovation Institute of the Hospital Parc Taulí de Sabadell (I3PT), Better Care, the company helps to optimize the care practice of all hospital services and the interaction with the patient and their families.
If you want to read more about the acquisition of DigitoMedica by Better Care and to find the latest business news of the day, download for free our companion app Born2Invest.
Better Care enhances its value proposition for the digital transformation of hospital management
“With this operation, we continue advancing in our strategic plan, reinforcing our position as a biotechnology company focused on the digital transformation of healthcare and increasing the value we offer to hospital managers”, according to Xavier García, CEO of Better Care.
In the same way, the company’s portfolio of technological solutions is expanding and is made up of different modules, fully interoperable with each other for the management of the monitored patient throughout the care route.
Among its solutions, there is BC Link from Better Care, a data integration platform (waves, vital signs, trends, and alarms) compatible with all complex monitoring devices connected to a patient that allows them to be processed, interpreted, and stored in real-time to track your status. These data can be used in the decision-making of the health team, the optimization of health resources, the formulation of medical hypotheses, and even the prediction of possible critical events.
In addition, BC Link is complemented by two incremental innovations: BC Workstation, an application that expands the visualization and allows advanced analysis of the complete evolution of a patient from the cardiology, hemodynamics, and ventilatory mechanics perspective; and BC Mview, a visualization module that automatically processes all the data of the monitored patient, centralizing all the information on a single screen and offering a direct and accessible view of the patient through an integrated and intuitive interface. In addition, Better Care incorporates DigitoMedica’s solutions, DigiCare and H-Connect, which complement BC Link.
__
(Featured image by geralt via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Impact Investing2 weeks ago
Sustainable Finance: What Are the Latest News on European Policies
-
Impact Investing3 days ago
Carbon Credit Markets Put to the Test by Donald Trump
-
Business1 week ago
Breaking Records with a Big Fat Zero: How the Dow Jones’ Highs Register as 0.0% in the BEV Plot
-
Africa2 weeks ago
Why It Is So Difficult to Build Mining Refineries in Africa